Ailong Liu - Nanhua Bio Deputy Manager
| 000504 Stock | 10.27 0.02 0.20% |
Executive
Ailong Liu is Deputy Manager of Nanhua Bio Medicine
| Age | 46 |
| Address | Lugu Science and Technology, Changsha, China, 410205 |
| Phone | 86 73 1858 10285 |
| Web | https://www.landfar.cn |
Nanhua Bio Management Efficiency
The company has return on total asset (ROA) of (0.0455) % which means that it has lost $0.0455 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.313) %, meaning that it generated substantial loss on money invested by shareholders. Nanhua Bio's management efficiency ratios could be used to measure how well Nanhua Bio manages its routine affairs as well as how well it operates its assets and liabilities. At present, Nanhua Bio's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 140.9 M, whereas Other Current Assets are forecasted to decline to about 6.9 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Xuheng Deng | Yili Chuanning Biotechnology | 37 | |
| Heng Han | Guangzhou Tinci Materials | 41 | |
| Zhao Hua | Yili Chuanning Biotechnology | 54 | |
| Na Huang | Guangzhou Tinci Materials | 41 | |
| Qiang Hu | GRIPM Advanced Materials | 51 | |
| Jingguo Zhang | GRIPM Advanced Materials | 50 | |
| Litao Shi | Guangzhou Tinci Materials | 39 | |
| Zhou Shaoxiong | Advanced Technology Materials | 69 | |
| Xuexin Zhu | GRIPM Advanced Materials | 56 | |
| Tiejun Wang | Advanced Technology Materials | 53 | |
| Meipeng Ma | Guangzhou Tinci Materials | 42 | |
| Xin Zhao | GRIPM Advanced Materials | 45 | |
| Zhe Chen | Advanced Technology Materials | 54 | |
| Zhanrong Li | GRIPM Advanced Materials | 45 | |
| Jin Wang | Advanced Technology Materials | 53 | |
Management Performance
| Return On Equity | -0.31 | ||||
| Return On Asset | -0.0455 |
Nanhua Bio Medicine Leadership Team
Elected by the shareholders, the Nanhua Bio's board of directors comprises two types of representatives: Nanhua Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nanhua. The board's role is to monitor Nanhua Bio's management team and ensure that shareholders' interests are well served. Nanhua Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nanhua Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Changqiao You, GM Director | ||
| Pengbin Lin, Deputy CFO | ||
| Ailong Liu, Deputy Manager | ||
| Liang Su, Secretary Board | ||
| Yong Chen, Deputy Manager |
Nanhua Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Nanhua Bio a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.31 | ||||
| Return On Asset | -0.0455 | ||||
| Profit Margin | (0.30) % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 3.09 B | ||||
| Shares Outstanding | 330.02 M | ||||
| Shares Owned By Insiders | 13.01 % | ||||
| Shares Owned By Institutions | 40.52 % | ||||
| Price To Book | 13.60 X | ||||
| Price To Sales | 26.78 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Nanhua Stock
Nanhua Bio financial ratios help investors to determine whether Nanhua Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nanhua with respect to the benefits of owning Nanhua Bio security.